Human
sperm motility stimulating activity of a sulfono glycolipid isolated from
Sri Lankan marine red alga Gelidiella acerosa
G.A.S.
Premakumara1, W.D. Ratnasooriya2,
L.M.V. Tillekeratne3, A.S. Amarasekare3,
Atta-Ur-Rahman4 1Natural
Products Development Group, Industrial Technology Institute (CISIR),
Colombo
7, Sri Lanka
2Department of Zoology & 3Chemistry, University
of Colombo, Colombo
03, Sri Lanka
4HEJ Research Institute of Chemistry, University of Karachi,
Karachi 32,
Pakistan
Asian
J Androl 2001 Mar;
3: 27-31
Keywords:
sperm
motility; stimulants; reproduction;
sulfono glycolipids; red alga; Gelidiella acerosa
Abstract
Aim:
To
evaluate the sperm motility stimulating activity of a sulfono glycolipid
(S-ACT-1) isolated from Gelidiella acerosa, a Sri Lankan marine red algae.
Methods: S-ACT-1,
a white amorphous powder was separated from more polar fractions
of
the hexane soluble of 1:1 CH2Cl2/MeOH extract and
subjected to 1H,
13C NMR and
IR Spectroscopy after reverse phase HPLC for identification. Effects of
S-ACT-1
on human sperm motility was assessed in vitro at 10, 100 and 1000 g/mL
concentrations
at 37 for 0,
5, 15, 30 and 60 min. Results: S-ACT-1 was identified as
a glycolipid sulfate. The lower dose increased the sperm motility slightly,
whilst
the medium dose significantly increased the motility (P<0.05)
from 5 min
of incubation reaching a peak at 15 min and
the stimulant effect was sustained throughout
the experimental period. Furthermore, the medium dose rendered 80% of
the
immotile viable sperm motile. In contrast, the highest dose impaired the
sperm motility.
The sperm stimulating activity of S-ACT-1 was dose-dependent and had
a bell-shaped dose response curve for all the 5 incubation periods. Conclusion: S-ACT-1
of Gelidiella acerosa is a Sulfono glycolipid. S-ACT-1 has a potent
sperm
motility stimulating activity in vitro and has the potential to be developed
into a sperm stimulant.
1
Introduction
The
potential of natural marine products for the development of
bio-active agents is enormous[1].
Red algae (Rodophyta), with over 555 genera[2] is virtually
an untapped resource for bio-active substances.
So far, we have reported several biological activities of different
red algal extracts: the antihypertensive[3] and antiimplantation[4]
activity of Gracilaria corticata,
the gastroprotective activity of Jania sp[5]
and the contraceptive activity of Gelidiella acerosa[4].
In
the course of bioassay guided fractionation of contraceptive substance
from
G. acerosa, we isolated a white amorphous solid (designated as S-ACT-1)
from
the more polar fractions of the hexane solubles.
As a part of our ongoing screening
programme, we tested S-ACT-1 for its effect on human sperm motility in vitro.
This paper reports the isolation, partial characterization and human
sperm motility
stimulating activity of S-ACT-1 of Sri Lankan marine red alga G. acerosa.
2
Materials
and methods
2.1
Collection and extraction of algae
Fresh
specimen of Gelidiella acerosa (family Gelidiaceae) were collected
from the coastal rocky reef of Beruwala in southern Sri Lanka.
The identity of algae was authenticated by Ms. P.M.A. Jayasooriya,
National Aquatic Resources Agency, Sri Lanka and the Late Professor S.
Balasubramaniam, Department of Botany, University of Peradeniya, Sri Lanka.
A voucher specimen is on deposit at the museum, Department of Zoology,
University of Colombo, Sri Lanka, under the registration number of RA7.
The collected samples were carefully separated from other associated
organisms (polychaets, small crustaceans and other macroscopic algae) and
debris, shade dried for 24 h and stored in 1:1 CH2Cl2/MeOH
solvent mixture (Petroleum Corporation, Colombo, Sri Lanka).
After 14 days, the solvent was decanted, filtered and concentrated
under vacuo at 301 to
obtain reddish-brown gummy crude extract (CE).
2.2
Isolation of Bio-active compound S-ACT-1
CE
100 g was dissolved in 10% H2O/MeOH and partitioned into hexane
(Petroleum corporation, Colombo, Sri Lanka).
Hexane soluble fraction (50 g) was then subjected to gel filtration
column chromatography over Sephadex LH20 (Pharmacia, Piscataway,
Sweden) eluting with 1:1 CH2Cl2/MeOH.
Fractions collected were pooled according to their similar TLC
(on pre-coated silica gel 60HF254 plates; Merk,
Darmatadt, Germany) patterns to yield 6 fractions (F1-F6)
(see scheme 1).
Fraction F5 was further fractionated over Bio-Sil
(200-400 mesh, Bio-Rad, Richmond, USA) column eluting with a gradient
of MeOH/CH2Cl2
(0%30%) to result in 4 different fractions (F1-F4)
according to similar TLC patterns.
S-ACT-1 containing fraction F4 (single bluish green
spot for vanillin-sulfuric in HPTLC, Merk, Darmatadt, Germany) was chromatographed
on HPLC (Waters model 510, Milford, USA) over reverse phase C18
-Bonda pack column (Waters, USA) eluting with 15% H2O/MeOH
(BDH, Poole, England) (flow rate=2.5 mL/min) to afford S-ACT-1 (major
peak). Solvents of
the major peak were evaporated to yield S-ACT-1 as a white amorphous powder.
Scheme
1. Isolation
scheme of S-ACT-1 from crude extract of Gelidiella acerosa.
2.3
Spectroscopy
1H
and 13C NMR for S-ACT-1 were recorded with a 500 MHz Bruker
NMR machine (Bruker,
Falladen, Switzerland) in CD3OD. IR spectrums were recorded
in KBr with a JASCO, FT/IR 5300 spectrophotometer
(JASCO, Tokyo, Japan).
2.4
Semen samples
Semen
samples were obtained from healthy adult donors through masturbation and
kept in sterilized containers.
The samples were allowed to liquefy for 15-30 min and those liquefied
within this period of time were subjected to standard semen analysis[6].
Ejaculates (n=6) with a volume of>1.5 mL,
sperm concentration >40106 spermatozoa/mL, >40% motile
sperm and >60% normal morphology sperm were used.
2.5
Evaluation of sperm motility stimulating activity
Dissolved
1 mg of S-ACT-1 in 500 L normal saline (0.9% NaCl, w/v) and stored at
4 until use.
The semen samples were diluted with normal saline to obtain the
desired concentration (40106 spermatozoa/mL). Three concentrations
(10, 100, 1000 g/mL) of S-ACT-1 were prepared from the stock solution
immediately before use.
One hundred L aliquots of semen were placed in clean glass vials
and equal volumes of test solutions or vehicle (normal saline) were added,
mixed well. Immediately after mixing (0 min) and at 5, 15, 30 and 60 min
of incubation, 10 L
aliquots were transferred onto clean slides, covered with 2222 mm cover
glass. The number of motile cells was counted under phase contrast optics
(400 magnification) at 37
using squared grid eye piece graticule.
Results were expressed as number of motile cells per 100 cells.
2.6
Evaluation of sperm viability
The
viability of spermatozoa was assessed using 0.5% Eosin-Y (Sigma, St. Louis,
USA) immediately before mixing with S-ACT-1 and after 15 min of incubation
with 100 g/mL S-ACT-1, according to the method described by Jeyendran
et al[7].
2.7
Statistical analysis
Results
are expressed as% meanSEM, if applicable. Data were analyzed by ANOVA,
followed by DNMRT. P<0.05 was considered significant.
3
Results
3.1
Isolation
Yield
of the CE was 2.71 g/kg. Fraction F5 resulted from column
chromatography over Sephadex LH20 was a yellowish white solid.
HPTLC of F5 developed in 15% MeOH/CH2Cl2
had a cluster of spots within Rf=0.0-0.3.
Bluish green spot for vanillin sulfuric at Rf-0.2 was the major
component. This was
concentrated to fraction F4 which resulted from gradient
elution of fraction F5 with 0-30% MeOH/CH2Cl2
over Biosil. Reverse
phase HPLC of F4 had one major peak (S-ACT-1) and a minor
peak.
3.2
Partial characterization
For
S-ACT-1, 1H NMR had 6H triplet at 1.3 (ca. 48 H; for long
alkyl chains) and mass of signals between 2.5 & 5.0 (for sugar
protons). 13C
NMR had 1 signal at 99.9 (for anomeric carbon) and 2 signals at 174.85
& 175.04 (for ester carbonyl groups).
IR spectrum had prominent bands at 1178 & 1035 cm-1
(for S=O stretchings).
These spectral evidences reveal that S-ACT-1 is a sulfated glycolipid.
3.3
Sperm motility
Results
of the sperm motility experiment are depicted in
Figure 1. S-ACT-1
increased the number of motile cells significantly at 100 g/mL concentration level.
This increment in motility was significant from the 5th min and
lasted throughout the incubation period.
Although not quantified, a marked increment in forward velocity
was also evident at this concentration. A similar trend was seen at the
10 g/mL concentration, however, the stimulation was statistically insignificant.
In contrast, with the 1000 g/mL concentration, an apparent but
insignificant reduction in motility could be observed.
The dose response curve for all 5 incubation periods had a bell
shape distribution (Figure 2).
Irrespective of the initial value, all six sperm samples reached
their maximum motility by 15 min of incubation at the 100 g/mL concentration.
Furthermore, motility increment
from 0 to 5 min was rapid compared to that
from 5 to 15 min in all the samples tested.
Figure
1. Effect of S-ACT-1 on motility of human spermatozoa in
vitro (time-response curve). ♦=Control;
=10 g/mL; =100 g/mL; =1000 g/mL (meanSEM, n=6). bP<0.05.
Figure 2. Effect of S-ACT-1
on motility of human spermatozoa in vitro (concentration-response
curve). ◊=0
min; =5 min; =15 min; ♦=30
min; =60 min
(meanSEM, n=6).
3.4
Sperm viability
Prior
to incubation with S-ACT-1, the mean sperm viability was 72.02.5% and
the mean motility was 53.432.85%. The motile fraction for viable
sperm was
74.03.86% and 26.03.86% of the viable spermatozoa were immotile. After
in cubation
for 15 min with 100 g/mL of S-ACT-1, the mean motility was
68.41.36%
with a mean viability of 72.33.3%. Thus, incubation with S-ACT-1
for 15 m in
induced 80% of immotile cells motile. 4
Discussion
The
results of this study demonstrated that S-ACT-1, isolated from Sri
Lankan
red alga, Gelidiella acerosa, is a sulfated glycolipid and this
compound markedly
increased the motility of human spermatozoa in vitro. This
is an important finding that may have therapeutic
and pharmaceutical potentials.
The
stimulatory effect on sperm motility was evident within 5 min of incubation.
This effect appeared to be concentration-dependent and displayed
a bell shape distribution. An obvious increment in the forward velocity
was also evident at the intermediate concentration.
Incubation
of sperm with S-ACT-1 induced 80% of immotile viable sperm motile.
Similar triggering of sperm motility has been demonstrated with
caffeine (65-75% by Ratnasooriya
et al[8]) a known sperm motility stimulant[9].
However, with caffeine the maximum sperm motility stimulation is
achieved instantaneously whereas with S-ACT-1, it is achieved after 15
minutes of incubation. It
is worthwhile to note
that the effective concentration of caffeine and pentoxifylline (the currently
used motility stimulant) required for maximal motility stimulation is
2.5 mmol/L[9] and 3.6 mmol/L[10], respectively,
whereas that of S-ACT-1 is only 0.123 mmol/L (molecular weight of S-ACT-1:
816)[11]. Accordingly, as a human sperm motility stimulant,
S-ACT-1 is approximately 20 and 28 times more potent than caffeine and
pentoxifylline, respectively.
The
precise mode of action of
the sperm stimulating effect of S-ACT-1 is unknown. However, it appears
to be receptor mediated,
due to a rapid onset of action[12] and a bell-shaped dose-response
curve[13]. Glycosaminoglycans
(GAGs) are natural sperm motility promoters and capacitating agents found
in the mammalian reproductive systems[14]. They are
highly sulfated glycoconjugates[14].
GAGs promote motility through increment
in intracellular cAMP concentration via enhancement of adenylate cyclase
activity[14,15]. Since S-ACT-1 is also a sulfated glycoconjugate,
its sperm motility promoting activity could also be mediated via a similar
mechanism.
Currently
there are only few known sperm motility stimulants, including caffeine[9],
heparin[14], theophylline[16], 2-deoxyadenosine[17],
pentoxiphylline[18]
and PAF[19]. Most
of these agents, including pentoxifylline[10],
have
drawbacks[20,21]. However, S-ACT-1 is unlikely to show such drawbacks[11].
There is a need and demand for new sperm stimulants to be used in asthenozoospermia
and in some assisted reproductive programmes.
It is believed that this finding
may lead to the development of a new potent sperm stimulant from sulfated
glycolipids.
The research on the motility stimulant effect of S-ACT-1 on asthenozoospermic
samples is underway. Acknowledgements
Financial
assistance from grants AP/3/ii/88/S/12 of University of Colombo and NRC-99.31
of National Research Council of Sri Lanka. UNESCO/ICSU for short-term
fellowship and NARESA/SAREC for travel grant to Dr.G.A.S. Premakumara.
References
[1]
Marion TD, Dean F.M, Padilla GM. Action of Marine Biotoxins at the Cellular
Level. In: Dean, FM, Padilla GM, editors. Marine Pharmacognosy. New York,
London: Academic Press;
1973. p 1-11.
[2] Groombridge B. Global Biodiversity. London:
Chapman and Hall; 1992. p 61.
[3] Ratnasooriya WD, Premakumara GAS, Tillekeratne LMV. Hypotensive activity
of crude extract of marine red algae, Gracilaria sp in rats. Vidyodaya
J Sci 1992; 3: 35-40.
[4] Ratnasooriya WD, Premakumara GAS, Tillekeratne LMV. Post-coital
contraceptive activity
of crude extract of Sri Lankan marine red algae. Contraception 1994; 50:
291-9.
[5] Ratnasooriya WD, Premakumara GAS, Tillekeratne LMV. Gastroprotective
activity of crude
extract of Jania sp (red algae) on ethanol-induced gastric lesions.
Med Sci Res 1990; 18: 803-4.
[6] WHO. Laboratory Manual for the Examination of Human Semen and Semen-Cervical Mucus
Interaction. New
York: Cambridge University Press; 1987. p 1-15.
[7] Jeyendran RS, Perez-Pelaez M, Crabo BG. Concentration of viable spermatozoa
for Artificial Insemination. Fertil Steril 1986; 45: 132-4.
[8] Ratnasooriya WD, Premakumara GAS. Effects of the prostonoid receptor
antagonist Di-4-phloretin phosphate upon human sperm motility. Contraception
1992; 45: 239-48.
[9] Aitken RJ, Best F, Richardson DW, Schats R, Simm G. Influence of Caffeine
on movement characteristics, fertilizing capacity and ability to penetrate
cervical mucus of
human spermatozoa. J Reporod Fert 1983; 67: 19-27.
[10] Tournaye H, Janssens MT, Camus M, Staessen C, Devroey P, Van Steirteghem
A. Pentoxifylline is not useful in enhancing sperm function in cases with
previous in vitro fertilization failure. Fertil Steril 1993; 59:
210-5.
[11] Premakumara GAS. Fertility regulating activities of some selected
Sri Lankan marine
red algae. University of Colombo, Sri Lanka; PhD Dissertation 1995.
p 143.
[12] Ratnasooriya WD, Premakumara GAS. Oxytocin suppresses motility of
human spermatozoa in vitro. Med Sci Res 1993; 21: 13-4.
[13] Horrobin DF. Interactions between prostaglandins and calcium: The
importance of bell-shaped dose-response curves. Prostaglandins 1977; 14:
667-77.
[14] Miller DJ, Ax RL. Carbohydrates and fertilization in animals. Mol
Reprod Develop 1990; 26: 184-98.
[15] Vacquier VD. Activation of sea urchin spermatozoa during fertilization.
TIBS 1986; 11: 77-81.
[16] Garbers DL, Lust WD, First NL, Lardy HA. Effects of phosphodiesterase
inhibitors and cyclic nucleotides on sperm respiration and motility. Biochemistry
1971a; 10: 1825-31.
[17] Aitken,RJ, Mattei A, Irvine S.
Paradoxical stimulation of human sperm motility by 2-deoxyadenosine.
J Reprod Fert 1986; 78: 515-27.
[18] Nassar A, Morshedi M, Mahoni M, Srisombut C, Lin MH, Oehninger S.
Pentoxifylline stimulates various sperm motion parameters and cervical
mucus penetrability in
patients with asthenozoospermia. Andrologia 1999; 31: 9-15.
[19] Ricker DD, Minhas BS, Kumar R, Robertson JL, Dodson MG. The effects
of platelet-activating factor on the motility of human spermatozoa. Fertil
Steril 1989; 4: 399-410.
[20] Lanzafame F, Chapman MG, Guglielmino A, Gearon CM, Forman RG. Pharmacological
stimulation of sperm motility. Hum Reprod 1994; 9:192-9.
[21] Tesarik J, Thebault A, Testart J. Effect of pentoxifylline on sperm
movement characteristics
in normozoospermic and asthenozoospermic specimens. Hum Reprod1992;
7: 1257-63.
home
Correspondence
to: Professor
W.D.Ratnasooriya, Department of Zoology, University of
Colombo, Colombo 03, Sri Lanka.
Tel: +94-1-503 399
Fax: +94-1-503148
e-mail: gasp@iti.lk
Received
2000-10-08 Accepted 2001-02-20
|